Skip to main content

Top header menu

  • Access to EMARKET SDIR
  • English
  • Italian
Home
EMARKET STORAGE - Teleborsa

Navigazione principale

  • Regulated Press releases
  • Regulated Documents
  • Support
  • Who we are
Menu

ALL Regulated Press Releases

Home Regulated Press releases
06/12/2020 - 07:27
DIASORIN
DiaSorin ha marcato CE il proprio test molecolare Simplexa™ Congenital CMV Direct
06/10/2020 - 15:40
DIASORIN
Shareholders' Meeting June 10, 2020
06/10/2020 - 15:39
DIASORIN
Assemblea degli Azionisti 10 giugno 2020
06/03/2020 - 14:15
DIASORIN
The LIAISON® SARS-CoV-2 S1 S2 IgG test receives the approval from ANVISA in Brazil
06/03/2020 - 14:14
DIASORIN
Il test sierologico LIAISON® SARS-CoV-2 S1 S2 IgG riceve l'approvazione da ANVISA per il mercato brasiliano
06/02/2020 - 15:00
DIASORIN
Communication voting rights amount
06/02/2020 - 14:58
DIASORIN
Comunicazione ammontare complessivo diritti di voto
05/18/2020 - 11:26
DIASORIN
DIASORIN - THE LIAISON® SARS-COV-2 S1S2 IGG TEST IS THE FIRST TO RECEIVE THE APPROVAL FROM HEALTH CANADA
05/18/2020 - 11:24
DIASORIN
DIASORIN - IL TEST SIEROLOGICO LIAISON® SARS-COV-2 S1S2 IGG È IL PRIMO A RICEVERE L’APPROVAZIONE DA HEALTH CANADA
05/13/2020 - 13:12
DIASORIN
DiaSorin - Q1 2020 results
05/13/2020 - 13:11
DIASORIN
Risultati DiaSorin - Q1 2020
05/11/2020 - 19:59
DIASORIN
DiaSorin S.p.A. - Shareholders' Meeting June 10, 2020 - Notice to call
05/11/2020 - 19:57
DIASORIN
DiaSorin S.p.A. - Assemblea degli Azionisti 10 giugno 2020 - Avviso di convocazione
05/08/2020 - 19:32
DIASORIN
Notice re: Annual Report
05/08/2020 - 19:31
DIASORIN
Avviso Relazione Finanziaria Annuale
04/29/2020 - 18:30
DIASORIN
Notice of availability Annual Report
04/29/2020 - 18:28
DIASORIN
Avviso disponibilita' Relazione Finanziaria Annuale
04/25/2020 - 16:30
DIASORIN
DiaSorin - FDA EUA and BARDA funding for SARS-CoV-2 IgG
04/25/2020 - 16:28
DIASORIN
DiaSorin riceve l'EUA dalla FDA americana sul test LIAISON® SARS-COV-2 S1/S2 IGG
04/22/2020 - 20:34
DIASORIN
Comunicato Internal Dealing
04/22/2020 - 15:49
DIASORIN
Comunicato Internal Dealing
04/22/2020 - 15:45
DIASORIN
Comunicato Internal Dealing
04/17/2020 - 18:22
DIASORIN
DIASORIN HAS CE MARKED ITS SARS-COV-2 IGG SEROLOGY KIT FOR COVID-19
04/17/2020 - 18:21
DIASORIN
DIASORIN HA MARCATO CE IL PROPRIO TEST SIEROLOGICO SARS-COV-2 IGG PER IL COVID-19

Pagination

  • First page « First
  • Previous page ‹ Precedente
  • …
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Current page 18
  • Page 19
  • Page 20
  • Page 21
  • Next page Seguente ›
  • Last page Last »

Footer menu

  • Disclaimer
  • Privacy
  • Cookies
  • Emergency assistance

Teleborsa - Logo

©Copyright 2022 Teleborsa S.r.l. No material on this site may be published, distributed, sold or reproduced in any form, whether printed or written, without the authorization of Teleborsa S.r.l.

  • Regulated Press releases
  • Regulated Documents
  • Support
  • Who we are